Nobel Biocare has launched creos syntoprotect, a dense PTFE membrane that the company says is easy to trim and versatile in its shaping and positioning. (Image: Nobel Biocare)
ZURICH, Switzerland: Dental implantology leader Nobel Biocare has expanded its portfolio of regenerative products with the launch of creos syntoprotect, a new line of dense PTFE membranes. According to the company, the expansion will allow creos—its regenerative solutions brand—to make a decisive movement towards meeting the ever-changing needs of dental professionals.
The creos syntoprotect dense PTFE membranes are designed to withstand exposure to the oral cavity for extraction socket management when primary closure is not possible. The line also offers 13 shapes of titanium-reinforced dense PTFE membranes for ridge augmentation and for grafting large osseous defects. Each of these options is easy to trim and versatile in its shaping and positioning, according to the company.
With the launch of syntoprotect, Nobel Biocare is presenting a new solution that is based on an established technology backed by more than 25 years of clinical practice.
“With syntoprotect, we aim to provide our customers with the confidence and peace of mind they are looking for,” said Philip Schulze-Smidt, vice president and general manager of regenerative solutions, business development and strategy at Nobel Biocare.
“The result is a line of synthetic solutions that promises to bring proven predictability1, 2 and efficacy3–5 to tissue and bone regeneration, while introducing attractive design features,” he added.
“Every patient is different; we know it, and our customers know it. Creos syntoprotect marks a turning point for our creos line, complementing our barrier membrane offering so we can provide dental professionals with natural and synthetic solutions for different indications, from a source they can trust,” Schulze-Smidt said.
Creos syntoprotect is now available in Europe and the US through either local Nobel Biocare sales representatives or the company’s online store. It will become available in additional geographical areas in the coming months.
For more information on creos and the new creos syntoprotect, dental professionals can visit nobelbiocare.com/creos.
Editorial note: A list of references can be obtained from the publisher.
ZURICH, Switzerland: Peri-implantitis is one of the greatest unsolved problems in dental implantology, and its prevalence is expected to increase over time ...
HALIFAX, Nova Scotia, Canada: A new clinic for Dalhousie University’s Faculty of Dentistry is set to be officially opened by the end of this month. ...
PARIS, France: At the congress of the European Association for Osseointegration (EAO), currently being held in Paris, dental implants manufacturer Nobel ...
ZURICH, Switzerland: At its 2019 Global Symposium in Madrid, Nobel Biocare will present a new implant system designed to challenge conventional methods of ...
COLOGNE, Germany: Nobel Biocare has invited dental professionals to join the Mucointegration era with the launch of the Xeal and TiUltra surfaces at IDS ...
ZURICH, Switzerland: A new and revolutionary chapter for implant dentistry will start this summer in Madrid in Spain. At the upcoming Nobel Biocare Global ...
BREA, Calif., U.S.: Envista is proud to announce the 2020 Nobel Biocare Global Symposium, to be held in Las Vegas from April 16 to 18. Empowered by a ...
LISBON, Portugal: This year, Nobel Biocare opened a new chapter for implant dentistry with the launch of new surfaces and the introduction of the new Nobel ...
SINGAPORE: At IDEM Singapore, which is taking place this weekend, from 13 to 15 April, visitors can see Nobel Biocare’s new full-arch solution in action: ...
LOS ANGELES, U.S.: SprintRay, a 3D printer manufacturer that focuses on digital dentistry, announced last week that it has commenced a partnership with the ...
KLOTEN, Switzerland: At the recent Envista Summit in Barcelona in Spain, Nobel Biocare announced its latest advancement in professional development: Zygoma ...
An 82-year-old patient presented for complete rehabilitation. The existing maxillary bridge showed Grade III mobility and the residual mandibular teeth ...
ZURICH, Switzerland: In a recent interview, Dr Tomas Albrektsson, professor emeritus of the Department of Biomaterials of the University of Gothenburg in ...
To post a reply please login or register